SELLAS Life Sciences Group Inc (GALE) Page

SELLAS Life Sciences Group Inc (GALE)

SELLAS Life Sciences Group is a biopharmaceutical company developing hematology and oncology therapeutics. Co.'s pipeline consists of multiple mid- to late-stage clinical assets, including its hematology asset, GALE-401, and its cancer immunotherapy programs including NeuVax™ (nelipepimut-S), GALE-301 and GALE-302. GALE-401 is a controlled release version of the approved drug anagrelide for the treatment of elevated platelets in patients with myeloproliferative neoplasms. NeuVax is in clinical trials in breast cancer. GALE-301 and GALE-302 have completed early stage trials in ovarian, endometrial and breast cancers.

GALE — Key Stats (updated Wed., Jan. 3, 10:31 AM)

Company Name:
SELLAS Life Sciences Group Inc
Website:
www.galenabiopharma.com
Sector:
Biotechnology

GALE — News

GALE — Price Chart

GALE — Current Quote

Quotes delayed 20 minutes

Free GALE Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Avg. Broker Rec.

Hold (2.00 out of 4)
100th percentile

(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

GALE — Performance

SELLAS Life Sciences Group Inc (GALE) Page | The Online Investor Page | www.TheOnlineInvestor.com

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.